3 Red-Hot Stocks for the 2nd Half of October
The Motley Fool
Published Dec 31, 0000 19:00
Updated Oct 15, 2018 16:46
What’s up, Fools? I’m back again to highlight three stocks that have recently touched new 52-week highs. As a quick refresher, I do this because stocks with improving fundamentals are superior to those with declining fundamentals; and stocks with price strength tend to break out even further over the near-term.
While buying quality stocks at good prices should be your priority, companies with both positive operating and price momentum shouldn’t be completely ignored.
Let’s get to those winners, shall we?
Trendy selection
Our first gainer is Aritzia (TSX:ATZ), which currently sits right by its 52-week high of $18.41. Year-to-date, shares of the fashion retailer are up an impressive 45% versus a loss of 12% for the S&P/TSX Capped Consumer Discretionary Index.
Aritzia has grown rapidly in recent years, and the momentum isn’t slowing. In its recent Q2 report, earnings tripled to $15.1 million on a revenue jump of 18%. More important, same-store sales — a key metric for retailers — increased a solid 11.5%, marking the 16th straight quarter of positive comparable growth. Demand was particularly strong in the U.S., where revenue spiked 40%.
The stock isn’t dirt cheap. But with a forward P/E in the high-teens and a PEG ratio of 1.2, Aritzia’s growth still seems reasonably priced.
Profitable pot pick
Next we have CannTrust Holdings (TSX:TRST), which hit a 52-week high of $14.24 just this past Friday. Over the past six months, shares of the medical cannabis producer are up a whopping 115%, while the S&P/TSX Capped Health Care Index has risen 72% over the same timeframe.
As my fellow Fool David Jagielski noted last week , CannTrust is actually profitable, making it a particularly special pot play. Over the first six months of 2018, the company earned $11.5 million as revenue more than doubled to $16.9 million.
Earlier this month, CannTrust announced a milestone of serving 50,000 patients, and said it now captures 36% of all newly registered patients in Canada. So, when you combine that strong operating momentum with the decent chance of a blockbuster deal in the future, CannTrust clearly has plenty of upside left.
Golden gainer
Our final flyer this week is Seabridge Gold (TSX:SEA) (NYSE:SA), whose shares hit a new 52-week high of $18.97 on Friday. Over the past six months, shares of the gold explorer are up an impressive 41% versus a loss of 6% for the S&P/TSX Capped Materials Index.
Get The App
A string of bullish updates over the past few months has helped Seabridge buck the gold slump . In August, the company said its KSM Project in B.C. is meeting objectives after early delays. And just last month, the stock surged after reporting a smaller-than-expected Q2 loss, as well as the discovery of two new gold zones at its Courageous Lake project in the Northwest Territories.
Seabridge’s positive operating trends, coupled with recent worries over the global economy, give the stock lots of room to run. And with zero debt on its balance sheet, Seabridge’s downside looks relatively limited, as well.
Fool on.
Brian Pacampara owns no position in any of the companies mentioned.
This Article Was First Published on The Motley Fool
Written By: The Motley Fool
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.